Original Contribution
The American Journal of Gastroenterology (2005) 100, 534–536; doi:10.1111/j.1572-0241.2005.41779.x
Gambling with Gastroesophageal Reflux Disease: Should We Worry about the QALY?
Paul Moayyedi PhD, FRCP1 and Nicholas J Talley MD, PhD1
1Department of Medicine Division of Gastroenterology, McMaster University Medical Centre, Hamilton, Ontario
Correspondence: Nicholas J. Talley, MD, PhD, Clinical Enteric Neuroscience Transational and Epidemiological Research Program, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota
Received 6 November 2004; Revised 0000; Accepted 9 November 2004.
Abstract
Gastroenterologists mainly deal with chronic organic and functional illnesses that are not life threatening but can be expensive to treat. How this compares with the management of other diseases that cause significant mortality is an important question to answer if health-care resources are to be allocated appropriately. Comparing health care in terms of cost per quality adjusted life year (QALY) gained is one approach to this problem although there are concerns about whose values should be elicited and how QALYs are measured.
